Article info

Download PDFPDF
Extended report
OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy

Authors

  1. Correspondence to Professor Peter C Taylor, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford Botnar Research Centre, Windmill Road, Headington, Oxford OX3 7LD, UK; peter.taylor{at}kennedy.ox.ac.uk
View Full Text

Citation

Taylor PC, Genovese MC, Greenwood M, et al
OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy

Publication history

  • Received February 6, 2014
  • Revised May 30, 2014
  • Accepted July 11, 2014
  • First published July 29, 2014.
Online issue publication 
November 10, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.